Clinical Trial Update: Safety and Immunogenicity of a New Formulation of Euvichol® [Phase 3]

View source ↗

Summary

This clinical trial update reports on safety and immunogenicity of a new formulation of Euvichol, an oral cholera vaccine, in Phase 3 testing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Euvichol (Rotavirus vaccine, live attenuated)

Snippet

Sponsor: International Vaccine Institute | Conditions: Cholera | Phase 3 | Status: UNKNOWN